JJJianping Jin

Jianping Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianping Jin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chonghua Li

    Department of Biochemistry and Molecular Biology, Medical School, United States

    2 shared publications
  • Ju-Mei Li

    Department of Biochemistry and Molecular Biology, Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA

    2 shared publications
  • Dorothy E. Lewis

    Department of Internal Medicine, Medical School, United States

    1 shared publication
  • Hongyu Wu

    Department of Internal Medicine, Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA

    1 shared publication
  • Michael R. Blackburn

    Department of Biochemistry and Molecular Biology, McGovern Medical School at UTHealth, Houston, Texas, USA

    1 shared publication
  • Natoya Peart

    Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, USA

    1 shared publication

Latest Publications

  • PMA induces SnoN proteolysis and CD61 expression through an autocrine mechanism

    by Chonghua Li, Natoya Peart, Zhenyu Xuan, Dorothy E. Lewis, Yang Xia, Jianping Jin


  • Open Access

    The p97-UFD1L-NPL4 Protein Complex Mediates Cytokine-Induced IκBα Proteolysis

    by Ju-Mei Li, Hongyu Wu, Wenzheng Zhang, Michael R. Blackburn, Jianping Jin

    IκBα is an inhibitor of NF-κB, a family of transcription factors that transactivate genes related to inflammation. Upon inflammatory stimuli, IκBα is rapidly degraded via the ubiquitin-proteasome pathway. While it is very clear that the SCFβ-TRCP ubiquitin ligase ubiquitinates IκBα upon stimulation, little is known about the postubiquitinational events of IκBα proteolysis. Here, we report that p97, a valosin-containing protein (also called VCP), plays an essential role in the postubiquitinational regulation of IκBα turnover after tumor necrosis factor alpha (TNF-α) or interleukin-1β (IL-1β) treatment. The ATPase activity of p97 is essential for its role in IκBα proteolysis. Moreover, we found that UFD1L and NPL4, two cofactors of p97, assist p97 to control the postubiquitinational regulation of IκBα. The p97-UFD1L-NPL4 protein complex specifically associates with ubiquitinated IκBα via the interactions between p97 and the SCFβ-TRCP ubiquitin ligase and between the polyubiquitin binding domain of UFD1L and polyubiquitinated IκBα. Furthermore, we observed that the postubiquitinational regulation of IκBα by the p97-UFD1L-NPL4 complex is important for NF-κB activation under stimuli.


  • Open Access

    CRL Ubiquitin Ligases and DNA Damage Response

    by Ju-Mei Li, Jianping Jin

    Cullin/RING ubiquitin ligases (CRL) comprise the largest subfamily of ubiquitin ligases. CRLs are involved in cell cycle regulation, DNA replication, DNA damage response (DDR), development, immune response, transcriptional regulation, circadian rhythm, viral infection, and protein quality control. One of the main functions of CRLs is to regulate the DDR, a fundamental signaling cascade that maintains genome integrity. In this review, we will discuss the regulation of CRL ubiquitin ligases and their roles in control of the DDR.


  • Open Access

    DNA replication licensing control and rereplication prevention

    by Chonghua Li, Jianping Jin

    Eukaryotic DNA replication is tightly restricted to only once per cell cycle in order to maintain genome stability. Cells use multiple mechanisms to control the assembly of the prereplication complex (pre-RC), a process known as replication licensing. This review focuses on the regulation of replication licensing by posttranslational modifications of the licensing factors, including phosphorylation, ubiquitylation and acetylation. These modifications are critical in establishing the pre-RC complexes as well as preventing rereplication in each cell cycle. The relationship between rereplication and diseases, including cancer and virus infection, is discussed as well.